Also known as: Sygnature Discovery
Sygnature Discovery is a contract research organization providing integrated drug discovery and preclinical services to biotechnology and pharmaceutical clients. It supports programs from hit identification through candidate nomination and beyond.
Sygnature Discovery, a drug discovery contract research organisation, has announced a strategic brand relaunch including a new website to cement its position as a global drug discovery partner across Europe and North America.
Sygnature Discovery announced a strategic brand relaunch on February 16, 2026, positioning itself as the only CRO offering full DMTA capabilities under one roof in both North America and Europe.
